H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one 14.5 fr d/l glidepath 23 cm str hemodialysis catheter with surecuff was returned for evaluation.Functional, gross visual, microscopic visual and tactile evaluations were performed.The investigation is inconclusive for catheter dislodgement and failed tissue in-growth on cuff.The cuff did not slide along the catheter under manual manipulation.The cuff appeared to be slightly variably patchy/thin in density content.There appeared to be an uneven distribution of blood/tissue residue throughout the cuff, with approximately one-half of the cuff having a substantial amount of blood/tissue residue and the half appearing to be sparse in blood/tissue residue.There appears to be a distinct, sharp boundary between the region with substantial blood/tissue residue and the region that appears to be sparse in blood/tissue residue.The fibers appeared to be matted throughout the cuff.Sutures were present in both holes of the suture wings.The definite root cause could not be determined based upon available information.It is unknown whether patient and/or procedural factors contributed to the event.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) showed that the product labeling is adequate.H10: d4 (expiration date: 04/2021); g4.H11: b5, h3, h6 (results and conclusion).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|